- Bruker's unit (NASDAQ:BRKR) Canopy Biosciences launched CellSpace system for spatial phenotyping in tissue analysis.
- The company said CellSpace is a next generation in ChipCytometryTM instrumentation that delivers single-cell targeted spatial proteomics for complex whole-tissue analysis of the tumor microenvironment, and deep immune profiling for use in immunology, neuroscience, and infectious disease.
- The company noted that the system will improve researchers’ workflow, accelerate spatial biology discovery, and drive broader adoption of high-plex spatial omics for clinical applications.
Recommended For You
More Trending News
See More »